Physician profile
Gregory Alan Cost
NPI 1104987635
$6,842.39
in general payments reported to CMS, 2019-2025
47 companies · $1,029 in 2025
The $1,029 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,568 · 2020: $280 · 2021: $119 · 2022: $681 · 2023: $994 · 2024: $1,170 · 2025: $1,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,995 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,994.60 |
| Education | $199.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,259.77 | 2019 | |
| Astellas Pharma US INC | $850.17 | 2019-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $499.28 | 2019-2025 | Botox |
| Pfizer INC. | $436.75 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $363.16 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $283.87 | 2023-2024 | Gemtesa, Orgovyx |
| Tolmar, INC. | $196.37 | 2023-2025 | Eligard, Jatenzo |
| Boston Scientific Corporation | $195.03 | 2019-2024 | Rezum Generator |
| Dendreon Pharmaceuticals LLC | $193.49 | 2019-2024 | Provenge |
| Janssen Biotech, INC. | $168.54 | 2019-2025 | |
| Convatec INC. | $163.06 | 2019-2025 | |
| Allergan, INC. | $148.24 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $141.08 | 2019-2024 | Aveed, Xiaflex |
| Accord Healthcare, INC. | $139.23 | 2023-2025 | |
| Coloplast Corp | $126.23 | 2019-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Northgate Technologies, INC. | $125.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $123.17 | 2023-2025 | Lynparza, Imfinzi |
| Progenics Pharmaceuticals, INC. | $122.27 | 2023-2025 | Pylarify |
| Merck Sharp & Dohme LLC | $119.94 | 2022-2025 | Keytruda, Lynparza |
| Olympus America INC. | $104.70 | 2025 | Itind System |
| Myriad Genetic Laboratories, INC. | $101.52 | 2022-2025 | Prolaris |
| Travere Therapeutics, INC. | $93.95 | 2019-2022 | |
| Antares Pharma, INC. | $92.37 | 2019-2020 | |
| Ethicon US, LLC | $90.60 | 2021-2024 | Echelon Flex, Echelon; Endopath |
| Endo USA, INC. | $76.68 | 2024-2025 | Xiaflex, Aveed |
| Lsi Solutions INC | $59.25 | 2023 | Running Device, Jnw Urtrac |
| 180 Medical, INC. | $56.41 | 2023-2024 | Cure Catheter |
| Valencia Technologies Corporation | $47.64 | 2025 | Ecoin Device Kit |
| Urogen Pharma, INC. | $43.23 | 2022-2023 | Jelmyto |
| Axonics, INC. | $43.00 | 2022 | |
| Agiliti Surgical, INC. | $41.69 | 2019 | |
| Myovant Sciences INC. | $39.01 | 2021 | |
| Cook Medical LLC | $29.82 | 2020-2022 | |
| Becton, Dickinson and Company | $28.32 | 2024 | Bard Urinary Drainage Bag |
| Amgen INC. | $27.58 | 2019 | |
| Blue Earth Diagnostics | $25.17 | 2019 | |
| Gilead Sciences, INC. | $24.29 | 2022 | |
| Medtronic Vascular, INC. | $21.40 | 2019 | |
| Telix Pharmaceuticals | $20.00 | 2022 | |
| Dornier Medtech America, INC | $19.09 | 2019 | |
| Baxter Healthcare | $19.05 | 2023 | Tisseel |
| Alnylam Pharmaceuticals INC. | $17.45 | 2023 | Oxlumo |
| Sun Pharmaceutical Industries INC. | $17.06 | 2024 | |
| Calyxo, INC. | $14.13 | 2025 | Cvac Aspiration System |
| Covidien LP | $13.25 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.54 | 2021 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Cost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.